$CADL

$8.95▲ +3.3% YTD

12 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

CADL ▲ +3.3% - Candel Therapeutics, Inc.

CP $8.95▲ +3.3%Oct 29, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene…

News

CADL ▲ +1.5% - Candel Therapeutics, Inc.

CP $7.90▲ +1.5%Oct 27, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics to Present at November Investor Conferences…

News

CADL ▲ +1.8% - Candel Therapeutics, Inc.

CP $8.52▲ +1.8%Oct 22, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Appoints Maria Ostrovsky as General Counsel…

News

CADL ▲ +1.2% - Candel Therapeutics, Inc.

CP $8.47▲ +1.2%Oct 22, 2026 · ThinkSabio Blog

$CADL int Buy @ Jefferies pt 25…

News

CADL ▲ +1.9% - Candel Therapeutics, Inc.

CP $10.36▲ +1.9%Oct 2, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics to Present at the SITC 2026 Annual Meeting…

News

CADL ▼ -2.6% - Candel Therapeutics, Inc.

CP $10.16▲ -2.6%Oct 1, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News

CADL ▼ -0.3% - Candel Therapeutics, Inc.

CP $10.40▲ -0.3%Oct 1, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Ag…

News

CADL ▲ +0.6% - Candel Therapeutics, Inc.

CP $10.96▲ +0.6%Sep 30, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimage…

News

CADL ▲ +0.6% - Candel Therapeutics, Inc.

CP $10.96▲ +0.6%Sep 30, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Loc…

News

CADL ▲ +1.1% - Candel Therapeutics, Inc.

CP $12.30▲ +1.1%Sep 10, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors…

News

CADL ▼ -2.2% - Candel Therapeutics, Inc.

CP $12.80▲ -2.2%Sep 1, 2026 · ThinkSabio Blog

$CADL - Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

SEC 13D/G

$CADL SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified

$10.15▲ 86.58%Jul 27, 2026 · ThinkSabio Blog

$CADL SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CADL : $10.15 Sector: Healthcare | YTD: 🔼+ 86.58% The SEC discl…